HD-OPM Archive
Topics › Statins

Statins cut stroke overall but may raise hemorrhagic stroke after prior stroke at low LDL

Louis Nervegna · Dec 23, 2023 · ♥ 5 reactions · 1 comments · original Facebook post
StatinsHeart attack, stroke & proceduresLDL, ApoB & lipid panel
AI summary & key facts

Louis reviews whether statins raise hemorrhagic stroke risk. Meta-analyses of RCTs in people who already had a stroke show lower overall stroke risk but higher hemorrhagic stroke when LDL is pushed very low. In people never having had a stroke, meta-analyses show no increase, though trials averaged under 5 years. For high-risk patients the benefit outweighs the small hemorrhagic risk, but those with strong family history of hemorrhagic stroke should discuss it with a doctor.

Do statins increase risk for hemorrhagic stroke?

Meta-analyses of RCT’s in patients at high risk of stroke (people who already had a stroke) show that statins decrease overall risk for stroke— but do increase risk for hemorrhagic stroke, when LDL is pushed very low. See links to these papers below. So the answer to this question is: possibly yes in certain circumstances (e.g. people who already had a stroke).

Paper · Ther Adv Neurol Disord · 2019Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis.Conclusion: Statin therapy in poststroke patients increased the risk of hemorrhagic stroke but effectively reduced ischemic stroke risk. Weighing the benefits and potential harms, statin has an overall beneficial effect in patients with previous stroke or TIA. However, more studies are required to investigate the conclusiveness of the increased hemorrhagic stroke risk revealed in our study.journals.sagepub.com PaperEurope PMC articleeuropepmc.org

Note that meta-analyses of RCT’s in people at more normal risk for stroke (people who have never had a stroke) do not show an increase in hemorrhagic stroke risk. But the caveat is that these trials were run for less than 5 years on average— so it is possible that a much longer trial would show an increased risk. See link to paper below.

PaperOxford Academic articleacademic.oup.com

This is one of the reasons why none of the major heart disease organizations (like the AHA) recommend using drugs to force LDL to very low levels (e.g. below 55 mg/dL) in people at low risk for CVD.

In people at high risk for CVD, the risk of a heart attack or thrombotic stroke far outweighs the small risk of a hemorrhagic stroke. But if you have a strong family history of hemorrhagic stroke, then you should talk to your doctor— and this should probably be factored into the risk/benefit analysis.

#hemorrhagicstrokeHD #statinsHD #strokeHD

Research cited

← newer: High-dose astaxanthin may risk crystalline maculopathy; sticolder: Case: carotid plaque regression with salmon, niacin and low- →